Kushner, Robert F.

Assessment and Lifestyle Management of Patients With Obesity: Clinical Recommendations From Systematic Reviews

Kushner, R. F., & Ryan, D. H. (2014) · JAMA

Obesity, Physical Activity, DietObesity and Health Practices

Cited by 235

8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes–2024

American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 213

Body composition changes during weight reduction with tirzepatide in the SURMOUNT ‐1 study of adults with obesity or overweight

Look, M., Dunn, J. P., Kushner, R. F., Cao, D., Harris, C., Gibble, T. H., Stefanski, A., & Griffin, R. (2025) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 181

Medical Nutrition Education, Training, and Competencies to Advance Guideline-Based Diet Counseling by Physicians: A Science Advisory From the American Heart Association

Aspry, K. E., Van Horn, L., Carson, J. A. S., Wylie-Rosett, J., Kushner, R. F., Lichtenstein, A. H., Devries, S., Freeman, A. M., Crawford, A., & Kris-Etherton, P. (2018) · Circulation

Innovations in Medical EducationDietetics, Nutrition, and Education

Cited by 171

New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics

Jastreboff, A. M., & Kushner, R. F. (2023) · Annual Review of Medicine

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 158

Introduction and Methodology: Standards of Care in Diabetes—2025

American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Bajaj, M., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Callaghan, B. C., et al. (2025) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 155

Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release

Garvey, W. T., Ryan, D. H., Bohannon, N. J. V., Kushner, R. F., Rueger, M., Dvorak, R. V., & Troupin, B. (2014) · Diabetes Care

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 149

Low priority of obesity education leads to lack of medical students’ preparedness to effectively treat patients with obesity: results from the U.S. medical school obesity education curriculum benchmark study

Butsch, W. S., Kushner, R. F., Alford, S., & Smolarz, B. G. (2020) · BMC Medical Education

Obesity and Health PracticesInnovations in Medical Education

Cited by 145

A standard calculation methodology for human doubly labeled water studies

Speakman, J. R., Yamada, Y., Sagayama, H., Berman, E. S. F., Ainslie, P. N., Andersen, L. F., Anderson, L. J., Arab, L., Baddou, I., Bedu-Addo, K., et al. (2021) · Cell Reports Medicine

Body Composition Measurement TechniquesClinical Nutrition and Gastroenterology

Cited by 143

Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses

Kosiborod, M. N., Bhatta, M., Davies, M., Deanfield, J. E., Garvey, W. T., Khalid, U., Kushner, R., Rubino, D. M., Zeuthen, N., & Verma, S. (2023) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 127

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials

O'Neil, P. M., Aroda, V. R., Astrup, A., Kushner, R., Lau, D. C. W., Wadden, T. A., Brett, J., Cancino, A., Wilding, J. P. H., & groups, O. B. O. T. S. A. C. A. –. L. E. I. I. W. A. W. D. (. S. (2017) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 115

Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics

Lingvay, I., Brown‐Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt‐Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., et al. (2023) · Obesity

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 113

Treating obesity seriously: when recommendations for lifestyle change confront biological adaptations

Ochner, C. N., Tsai, A. G., Kushner, R. F., & Wadden, T. A. (2015) · The Lancet Diabetes & Endocrinology

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 110

Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study

Wilding, J. P. H., Batterham, R. L., Calanna, S., Van Gaal, L. F., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wharton, S., Yokote, K., Zeuthen, N., et al. (2021) · Journal of the Endocrine Society

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 107

Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials

Verma, S., Bhatta, M., Davies, M., Deanfield, J. E., Garvey, W. T., Jensen, C., Kandler, K., Kushner, R. F., Rubino, D. M., & Kosiborod, M. N. (2023) · eClinicalMedicine

Adipokines, Inflammation, and Metabolic DiseasesPharmacology and Obesity Treatment

Cited by 106

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Bohula, E. A., Scirica, B. M., Inzucchi, S. E., McGuire, D. K., Keech, A. C., Smith, S. R., Kanevsky, E., Murphy, S. A., Leiter, L. A., Dwyer, J. P., et al. (2018) · The Lancet

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 94

Total daily energy expenditure has declined over the past three decades due to declining basal expenditure, not reduced activity expenditure

Speakman, J. R., de Jong, J. M. A., Sinha, S., Westerterp, K. R., Yamada, Y., Sagayama, H., Ainslie, P. N., Anderson, L. J., Arab, L., Bedu-Addo, K., et al. (2023) · Nature Metabolism

Obesity, Physical Activity, DietRegulation of Appetite and Obesity

Cited by 67

Weight History in Clinical Practice: The State of the Science and Future Directions

Kushner, R. F., Batsis, J. A., Butsch, W. S., Davis, N., Golden, A., Halperin, F., Kidambi, S., Machineni, S., Novick, M., Port, A., et al. (2020) · Obesity

Obesity and Health PracticesObesity, Physical Activity, Diet

Cited by 55

Incretin-Based Therapies and Lifestyle Interventions: The Evolving Role of Registered Dietitian Nutritionists in Obesity Care

Gigliotti, L., Warshaw, H., Evert, A., Dawkins, C., Schwartz, J., Susie, C., Kushner, R., Subramanian, S., Handu, D., & Rozga, M. (2025) · Journal of the Academy of Nutrition and Dietetics

Pharmacology and Obesity TreatmentDietetics, Nutrition, and Education

Cited by 53

Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial

Kushner, R. F., Ryan, D. H., Deanfield, J., Kokkinos, A., Cercato, C., Wilding, J., Burguera, B., Wu, C., Craciun, A., Pall, D., et al. (2025) · Obesity

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 35

Total energy expenditure is repeatable in adults but not associated with short-term changes in body composition

Rimbach, R., Yamada, Y., Sagayama, H., Ainslie, P. N., Anderson, L. F., Anderson, L. J., Arab, L., Baddou, I., Bedu-Addo, K., Blaak, E. E., et al. (2022) · Nature Communications

Obesity, Physical Activity, DietRegulation of Appetite and Obesity

Cited by 19

Age no Impediment to Effective Weight Loss with Liraglutide 3.0 Mg: Data from Two Randomized Trials

Rubino, D., Coelho, R., Kahan, S., Kushner, R., Wilding, J., Jepsen, C., Smolarz, G., & Wyatt, H. (2018) · International Journal of Nutrology

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 4

Aspiration Therapy for the Treatment of Obesity: 2-4 Year Results of the PATHWAY Multicenter Randomized Controlled Trial

Thompson, C. C., Dayyeh, B. K. A., Kushnir, V., Kushner, R. F., Schorr, A. B., Aronne, L. J., Amaro, A., Jaffe, D. L., Schulman, A. R., Early, D., et al. (2018) · Surgery for Obesity and Related Diseases

Bariatric Surgery and OutcomesPharmacology and Obesity Treatment

Cited by 3